NYSE: ABBVAbbVie Inc Stock Forecast, Predictions & Price Target
Analyst price target for ABBV
Based on 9 analysts offering 12 month price targets for AbbVie Inc.
Min Forecast
$93.00-13.52%
Avg Forecast
$116.89+8.69%
Max Forecast
$144.00+33.9%
Should I buy or sell ABBV stock?
Strong Buy
Strong Buy
5 analysts 55.56%
Buy
4 analysts 44.44%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
ABBV stock forecasts by analyst
| Analyst / Firm | Rating | Action | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|
David Risinger Morgan Stanley | Strong Buy | Maintains | $116.00 | +7.87% | 2021-01-28 |
Andrew Baum Citigroup | Strong Buy | Maintains | $105.00 | -2.36% | 2020-09-02 |
Steve Chesney Atlantic Equities | Strong Buy | Upgrades | $115.00 | +6.94% | 2020-06-23 |
David Toung Argus Research | Strong Buy | Upgrades | $115.00 | +6.94% | 2020-06-02 |
Navin Jacob UBS | Strong Buy | Maintains | $96.00 | -10.73% | 2020-04-13 |
Anonymous SVB Leerink | Buy | Maintains | $144.00 | +33.90% | 2021-03-30 |
Geoff Porges SVB Leerink | Buy | Maintains | $140.00 | +30.18% | 2021-02-04 |
Geoffrey Porges SVB Leerink | Buy | Maintains | $128.00 | +19.03% | 2020-12-16 |
Randall Stanicky RBC Capital | Buy | Upgrades | $93.00 | -13.52% | 2020-04-20 |
Forecast return on equity
Is ABBV forecast to generate an efficient return?
Company
167.22%
Industry
76.5%
Market
32,279.67%
ABBV's Return on Equity is forecast to be high in 3 years (167.22%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast
Forecast return on assets
Is ABBV forecast to generate an efficient return on assets?
Company
14.52%
Industry
16.91%
Market
11,627.87%
ABBV is forecast to generate lower Return on Assets (14.52%) than the US Drug Manufacturers - General industry average (16.91%)
Forecast
ABBV earnings per share forecast
What is ABBV's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$12.50+357.88%
Avg 2 year Forecast
$13.92+409.89%
Avg 3 year Forecast
$12.06+341.76%
ABBV's earnings are forecast to grow at an exceptional rate of 67.34% per year
Forecast
ABBV revenue forecast
What is ABBV's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$55.8B+21.9%
Avg 2 year Forecast
$59.7B+30.31%
Avg 3 year Forecast
$56.2B+22.8%
ABBV's revenue is forecast to grow at a rate of 7.85% per year, which is not exceptional
Forecast
ABBV earnings growth forecast
How is ABBV forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
67.34%
Industry
34.05%
Market
23.11%
ABBV's earnings are forecast to grow faster (67.34% per year) than the US Drug Manufacturers - General industry average (34.05%)
Forecast
ABBV's earnings are forecast to grow faster (67.34% per year) than the US market average (23.11%)
Forecast
ABBV's earnings are forecast to grow faster (67.34% per year) than the risk-free savings rate (1.7%)
Forecast
ABBV revenue growth forecast
How is ABBV forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
7.85%
Industry
5.94%
Market
15.02%
ABBV's revenues are forecast to grow faster (7.85% per year) than the US Drug Manufacturers - General industry average (5.94%)
Forecast
ABBV's revenues are forecast to grow slower (7.85% per year) than the US market average (15.02%)
Forecast
AbbVie Stock Forecast FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.